Sitagliptin Fumarate Adduct

Sitagliptin Fumarate Adduct is a medication used to treat type 2 diabetes. It is an oral hypoglycemic agent that works by increasing insulin secretion from the pancreas and reducing the amount of glucose produced by the liver. This medication is usually taken in conjunction with a healthy diet and regular exercise. Sitagliptin Fumarate Adduct is a combination of sitagliptin and fumaric acid. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which means it blocks an enzyme in the body that breaks down incretin hormones. Incretin hormones are responsible for increasing insulin production and decreasing glucose levels in the body. By inhibiting the breakdown of these hormones, Sitagliptin Fumarate Adduct increases their effectiveness in regulating blood sugar levels. Fumaric acid, on the other hand, is a naturally occurring organic acid that is used in the pharmaceutical industry as a pH adjuster. Sitagliptin Fumarate Adduct is available in tablet form and is usually taken once a day with or without food. The dosage may vary depending on the patient's age, medical history, and response to treatment. Side effects may include nausea, vomiting, diarrhea, and headache. It is important to follow the dosage and timing instructions provided by the healthcare provider to ensure maximum effectiveness and minimize potential side effects.